Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies

BACKGROUND: Ovarian cancer causes more deaths than any other gynecological cancer. Identifying the molecular mechanisms that drive disease progress in ovarian cancer is a critical step in providing therapeutics, improving diagnostics, and affiliating clinical behavior with disease etiology. Identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Hamo, Rotem, Efroni, Sol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298526/
https://www.ncbi.nlm.nih.gov/pubmed/22236809
http://dx.doi.org/10.1186/1752-0509-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298526/
https://www.ncbi.nlm.nih.gov/pubmed/22236809
http://dx.doi.org/10.1186/1752-0509-6-3

Ejemplares similares